Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway

PURPOSE: Vascular endothelial growth factor (VEGF) family members contribute greatly to the development and angiogenesis of hypervascular hepatocellular carcinoma (HCC). We have previously shown that Dicer inhibited HCC growth. In this study, we aimed to determine the relationship between Dicer and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cuiju, Lv, Yalei, Sha, Ziyue, Zhang, Jingjing, Wu, Jianhua, Qi, Yixin, Guo, Zhanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721026/
https://www.ncbi.nlm.nih.gov/pubmed/35004391
http://dx.doi.org/10.2147/JHC.S327258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721026/
https://www.ncbi.nlm.nih.gov/pubmed/35004391
http://dx.doi.org/10.2147/JHC.S327258

Ejemplares similares